Sozialstiftung Bamberg Medizinisches Versorgungszentrum am Bruderwald gGmbH

At Sozialstiftung Bamberg Medizinisches Versorgungszentrum am Bruderwald gGmbH, a large share of the clinical research focuses on neoplasms and hematologic malignancies. Studies are exploring better treatment options for acute myeloid leukemia, multiple myeloma, and several forms of lymphoma, with the goal of improving response rates, delaying disease progression, and reducing treatment-related burden.

• New approaches for acute myeloid leukemia and high-risk blood cancers
• Treatment optimization in multiple myeloma, including relapsed and newly diagnosed disease
• Therapy evaluation in diffuse large B-cell lymphoma and follicular lymphoma

This research reflects a strong interest in testing more effective and better-tolerated therapies for cancers that often require long-term, individualized care.

The site also conducts extensive work in breast cancer and other solid tumors, especially metastatic colorectal cancer. These trials are designed to compare new treatment combinations, assess disease control, and support longer progression-free survival in people with advanced or high-risk cancer.

• Research in advanced breast cancer, including hormone receptor-positive and HER2-negative disease
• Studies in locally advanced and metastatic breast cancer to improve treatment effectiveness
• Evaluation of therapies for metastatic colorectal cancer and primary high-risk lobular breast cancer

These efforts aim to identify therapies that can better control advanced cancer while preserving quality of life.

Another important area of research at the Bamberg site is digestive system diseases and immune system diseases. Trials are examining new ways to relieve symptoms and improve disease control in ulcerative colitis, celiac disease, irritable bowel syndrome, and gastroparesis.

• Testing therapies for ulcerative colitis and related inflammatory bowel conditions
• Symptom-focused studies in irritable bowel syndrome and functional gastrointestinal disorders
• Research in celiac disease and gastroparesis to improve digestive comfort and daily functioning

The purpose of this work is to find treatments that are more effective for symptom relief and easier for patients to tolerate over time.

The clinical trial portfolio also includes studies in cardiovascular diseases, nutritional and metabolic diseases, musculoskeletal diseases, and kidney-related conditions. Researchers are evaluating new options for chronic kidney disease with hypertension, rheumatoid arthritis, and cartilage defects of the knee joint, alongside broader studies that aim to improve long-term health outcomes.

• Investigations in chronic kidney disease and hypertension to reduce disease progression
• Studies in moderately active rheumatoid arthritis to better control inflammation and symptoms
• Research on cartilage repair for knee joint injury and joint preservation

Overall, this work supports the development of therapies that may improve function, slow disease worsening, and address unmet needs across several chronic conditions.